Valuation: Inogen, Inc.

Market Cap 16Cr 14Cr 13Cr 12Cr 23Cr 1.52TCr 23Cr 159Cr 62Cr 778.61Cr 59Cr 58Cr 2.5TCr P/E 2026 *
-7.8x
P/E 2027 * -12.6x
Enterprise Value 16Cr 14Cr 13Cr 12Cr 23Cr 1.52TCr 23Cr 159Cr 62Cr 778.61Cr 59Cr 58Cr 2.5TCr EV / Sales 2026 *
0.44x
EV / Sales 2027 * 0.43x
Free-Float
87.05%
Yield 2026 *
-
Yield 2027 * -
1 day-0.17%
1 week+11.38%
Current month+13.28%
1 month+10.76%
3 months-9.55%
6 months-3.86%
Current year-11.16%
1 week 5.26
Extreme 5.265
6.16
1 month 5.04
Extreme 5.045
6.16
Current year 5.04
Extreme 5.045
7.67
1 year 5.04
Extreme 5.045
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
44.3
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 10/11/2023
Director of Finance/CFO 48 06/04/2026
Chief Operating Officer 56 06/07/2026
Director TitleAgeSince
Director/Board Member 66 06/08/2014
Chairman 65 29/12/2021
Director/Board Member 59 22/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Controller/Auditor

1,500 0.0057%
01/09/26 Free

General Counsel

46,443 0.1750%
01/09/26 Free

Chief Executive Officer

1,500 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%+11.38%-30.01%+15.25% 16Cr
+0.84%-3.74%-26.69%+1.85% 17TCr
-0.07%-2.55%-9.53%+11.07% 11TCr
+0.90%+1.13%-24.83%+0.58% 11TCr
-1.24%-0.76%-49.04%-12.75% 7.39TCr
-0.24%+0.69%+0.16%+72.58% 5.9TCr
-0.86%+2.96%+13.57%+59.50% 5.13TCr
-0.71%-3.82%-7.72%-31.41% 4.82TCr
+0.12%-0.17%-18.21%+20.29% 4.08TCr
-1.01%-1.45%+28.48%-9.72% 3.22TCr
Average -0.24%+0.37%-12.38%+12.72% 6.9TCr
Weighted average by Cap. +0.03%-1.29%-16.37%+10.13%

Financials

2026 *2027 *
Net sales 36Cr 32Cr 30Cr 27Cr 51Cr 3.43TCr 51Cr 357.67Cr 138.6Cr 1.75TCr 133.81Cr 130.91Cr 5.62TCr 37Cr 33Cr 31Cr 28Cr 53Cr 3.58TCr 54Cr 373.93Cr 144.9Cr 1.83TCr 139.89Cr 136.86Cr 5.88TCr
Net income -2.08Cr -1.85Cr -1.72Cr -1.57Cr -2.97Cr -199.96Cr -2.99Cr -21Cr -8.09Cr -102.22Cr -7.81Cr -7.64Cr -328.06Cr -1.34Cr -1.19Cr -1.11Cr -1.01Cr -1.9Cr -128.34Cr -1.92Cr -13Cr -5.19Cr -66Cr -5.01Cr -4.9Cr -210.56Cr
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
02/26/02 $5.970 -0.17% 4,26,817
01/26/01 $5.980 +13.47% 11,05,406
30/26/30 $5.270 -1.86% 2,67,486
29/26/29 $5.370 -1.29% 2,31,991
28/26/28 $5.440 +1.49% 3,01,882
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.970USD
Average target price
12.00USD
Spread / Average Target
+101.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock